Our Science

Patent-pending production technology

Using proprietary RecombiPure (RP) protein expression technology, Antoxerene is able to recombinantly express hard or impossible to manufacture protein targets in a full-length, biologically active form. The basis of this technology is a combination solubility/affinity tag derived from a thermophile. Due to its thermophilic origin, the tag is stable, inexpensive, small, and possesses antibody level binding affinities.

Assays to target protein-drug and protein-protein interactions

High throughput screening assays are developed, validated and scaled on liquid handling robotics systems using state-of-the-art microplate technologies. Using these screens, staff scientists can identify lead compounds that disrupt molecular pathways implicated in disease onset and progression.